Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Durogesic DTrans 75micrograms/hour transdermal patches
0407020A0BBAKAG
|
Durogesic | Fentanyl | Central Nervous System | 2,706 |
|
Mezolar Matrix 75micrograms/hour transdermal patches
0407020A0BFADAG
|
Mezolar Matrix | Fentanyl | Central Nervous System | 2,671 |
|
Mezolar Matrix 100micrograms/hour transdermal patches
0407020A0BFAEAH
|
Mezolar Matrix | Fentanyl | Central Nervous System | 2,661 |
|
Fentanyl 100micrograms/hour transdermal patches
0407020A0AAAHAH
|
Fentanyl | Fentanyl | Central Nervous System | 2,645 |
|
Opiodur 50micrograms/hour transdermal patches (Zentiva)
0407020A0BRAMAF
|
Opiodur | Fentanyl | Central Nervous System | 2,065 |
|
Abstral 100microgram sublingual tablets
0407020A0BJAAAW
|
Abstral | Fentanyl | Central Nervous System | 1,035 |
|
Opiodur 75micrograms/hour transdermal patches (Zentiva)
0407020A0BRANAG
|
Opiodur | Fentanyl | Central Nervous System | 833 |
|
Opiodur 100micrograms/hour transdermal patches (Zentiva)
0407020A0BRAPAH
|
Opiodur | Fentanyl | Central Nervous System | 778 |
|
Abstral 200microgram sublingual tablets
0407020A0BJABAX
|
Abstral | Fentanyl | Central Nervous System | 561 |
|
Fentanyl 200microgram lozenges
0407020A0AAAIAI
|
Fentanyl | Fentanyl | Central Nervous System | 535 |
|
Fentanyl 400microgram lozenges
0407020A0AAAJAJ
|
Fentanyl | Fentanyl | Central Nervous System | 345 |
|
Fentanyl 100microgram sublingual tablets sugar free
0407020A0AAAWAW
|
Fentanyl | Fentanyl | Central Nervous System | 318 |
|
Fentanyl 100microgram buccal tablets sugar free
0407020A0AABCBC
|
Fentanyl | Fentanyl | Central Nervous System | 296 |
|
Fentanyl 200microgram sublingual tablets sugar free
0407020A0AAAXAX
|
Fentanyl | Fentanyl | Central Nervous System | 256 |
|
Actiq 200microgram loz with integral oromucosal applicator
0407020A0BCAAAI
|
Actiq | Fentanyl | Central Nervous System | 245 |
|
Fentanyl 200microgram buccal tablets sugar free
0407020A0AABDBD
|
Fentanyl | Fentanyl | Central Nervous System | 242 |
|
Yemex 25micrograms/hour transdermal patches
0407020A0BVABAE
|
Yemex | Fentanyl | Central Nervous System | 228 |
|
Yemex 12micrograms/hour transdermal patches
0407020A0BVAAAU
|
Yemex | Fentanyl | Central Nervous System | 222 |
|
Actiq 400microgram loz with integral oromucosal applicator
0407020A0BCABAJ
|
Actiq | Fentanyl | Central Nervous System | 215 |
|
Abstral 400microgram sublingual tablets
0407020A0BJADAZ
|
Abstral | Fentanyl | Central Nervous System | 212 |
|
Fentanyl 600microgram lozenges
0407020A0AAAKAK
|
Fentanyl | Fentanyl | Central Nervous System | 189 |
|
Effentora 200microgram buccal tablets
0407020A0BKABBD
|
Effentora | Fentanyl | Central Nervous System | 159 |
|
Yemex 50micrograms/hour transdermal patches
0407020A0BVACAF
|
Yemex | Fentanyl | Central Nervous System | 158 |
|
Fentanyl 400microgram buccal tablets sugar free
0407020A0AABEBE
|
Fentanyl | Fentanyl | Central Nervous System | 149 |
|
Effentora 100microgram buccal tablets
0407020A0BKAABC
|
Effentora | Fentanyl | Central Nervous System | 141 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.